We see some clinical trials in the future:
- The major research being performed at the Broad Institute (Broad Institute Link – Click Here) in Boston is scheduled to be completed in the next 8-12 weeks. Once the data is collected, data analysis will take another 4-6 weeks. The analysis of the data will yield potential targets for various types of immuno-therapy and provide information to begin clinical trials based on the findings. The best case scenario is where the data shows targets for which there are agents already tested and approved for cancer treatment.
- While we wait for the data from the first trial, we are looking into a reverse strategy. There may be some agents that are approved for other cancers that may be effective for carcinosarcoma. We think that launching a clinical trial with one or several types of immuno-therapy that are working for other cancers may provide some benefit to women with carcinosarcoma. Both MGH and UAB are talking to drug companies about sponsoring these trials. These trials would be at least six months away.